MoneyWorks4Me

A decrease in the sales to Rs. 17300.00 millions was observed for the quarter ended June 2023. The sales stood at Rs. 22040.00 millions during the similar quarter previous year.The Net Profit of the company slipped to Rs. 3450.00 millions from Rs. 6910.00 millions, a decline of -50.07% on QoQ basis.A decline of 5710.00 millions was observed in the OP in the quarter ended June 2023 from 9270.00 millions on QoQ basis.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202306 202206 % Var 202306 202206 % Var 202303 202203 % Var
Sales 17300.00 22040.00 -21.51 17300.00 22040.00 -21.51 76253.00 88798.20 -14.13
Other Income 800.00 900.00 -11.11 800.00 900.00 -11.11 3490.10 1112.60 213.69
PBIDT 5710.00 9270.00 -38.40 5710.00 9270.00 -38.40 26966.90 39877.20 -32.38
Interest 0.00 0.00 0.00 0.00 0.00 0.00 5.20 6.50 -20.00
PBDT 5710.00 9270.00 -38.40 5710.00 9270.00 -38.40 26961.70 39870.70 -32.38
Depreciation 930.00 830.00 12.05 930.00 830.00 12.05 3420.70 3105.50 10.15
PBT 4780.00 8440.00 -43.36 4780.00 8440.00 -43.36 23541.00 36765.20 -35.97
TAX 1330.00 1530.00 -13.07 1330.00 1530.00 -13.07 5459.50 7279.80 -25.00
Deferred Tax 100.00 150.00 -33.33 100.00 150.00 -33.33 1083.70 907.80 19.38
PAT 3450.00 6910.00 -50.07 3450.00 6910.00 -50.07 18081.50 29485.40 -38.68
Equity 530.00 530.90 -0.17 530.00 530.90 -0.17 530.90 530.90 0.00
PBIDTM(%) 33.01 42.06 -21.53 33.01 42.06 -21.53 35.37 44.91 -21.25
Peers
Company Name CMP
Sun Pharma. Inds. 1759.10
Dr. Reddys Labs. 1230.50
Cipla 1313.70
Lupin 1946.00
Zydus Lifesciences 1139.00
View more..